Food Is Medicine in Viet Nam: Evidence for Produce Prescriptions, Medically Tailored Meals, and Responsible Implementation

RESEARCH & IMPLEMENTATIONHEALTH EQUITY & PLANETARY HEALTH

11/21/202628 min read

Food Is Medicine in Viet Nam: Evidence for Produce Prescriptions, Medically Tailored Meals, and Responsible Implementation

Last reviewed: November 21, 2026

A patient with type 2 diabetes may leave a medical consultation knowing what a healthier diet should look like. The clinician has explained the importance of dietary quality, appropriate portions and regular meals. Yet following that advice may be difficult when household finances are limited, work schedules are unpredictable or suitable foods are not readily available.

For some patients, the problem is not a lack of knowledge or motivation. They may understand the recommendations but lack the resources, time or practical support to follow them consistently. Repeating the same dietary advice at subsequent appointments may do little to address those barriers.

This gap between clinical recommendations and everyday food access has contributed to growing international interest in Food Is Medicine (FIM). The term describes approaches that connect healthcare with practical assistance in obtaining and consuming nutritious food, particularly for people whose medical conditions and social circumstances make healthy eating difficult.

The discussion gained further attention in September 2026, when the American College of Cardiology (ACC) published a scientific statement on nutrition in cardiovascular disease prevention and management. The statement recognized Food Is Medicine programs as an emerging approach to translating nutrition evidence into clinical practice, alongside dietary counseling, medical nutrition therapy, public health initiatives and professional education.[1]

However, providing healthy food and demonstrating clinical effectiveness are not the same thing. Research suggests that some programs improve access to nutritious food, dietary quality and food security. Their effects on disease control, hospital utilization and healthcare expenditure are less consistent.

For Viet Nam, Food Is Medicine offers an opportunity to examine how clinical nutrition care might be connected with practical assistance for patients who struggle to obtain appropriate food. It also raises questions about professional responsibilities, food safety, patient selection, financing, personal-data protection and the evidence needed to justify implementation.

The important question is whether providing food through a healthcare-connected program delivers meaningful additional benefits, which patients are most likely to benefit and whether the approach can be implemented safely and sustainably.

What Does Food Is Medicine Mean?

Food Is Medicine is an umbrella term used internationally for interventions that seek to improve health by addressing barriers to obtaining and consuming nutritious food.

In the United States, where much of the published research has been conducted, these programs commonly provide free or subsidized food to people with nutrition-related health needs. They may involve hospitals, primary care clinics, health plans, community organizations, food suppliers, retailers or charitable foundations.

The connection with healthcare helps distinguish these interventions from ordinary food retail or general nutrition promotion. A program typically identifies a health-related need, offers an organized form of food assistance and aims to improve specified nutritional, social or clinical outcomes.

Food Is Medicine should nevertheless be distinguished from other approaches to nutrition care.

Dietary counseling helps people understand which foods and eating patterns may support their health. Medical nutrition therapy involves individualized nutritional assessment and management by appropriately qualified healthcare professionals. Culinary medicine focuses on translating nutrition knowledge into practical skills such as meal planning, food selection and preparation.

Food Is Medicine addresses a closely related but different concern: whether patients can obtain and use the foods recommended for their circumstances.

A patient may receive excellent nutritional counseling but still be unable to afford appropriate groceries. Conversely, providing nutritious food may not adequately address the needs of someone who requires specialized dietary management because of kidney disease, malnutrition, swallowing difficulties or another medical condition.

These approaches can complement one another. Food assistance does not replace clinical nutrition care, and professional dietary counseling cannot always resolve the financial, environmental or social barriers that prevent patients from following recommendations.

The terminology also requires restraint. Food Is Medicine does not mean that ordinary foods are pharmaceutical treatments or that particular foods can independently cure chronic diseases. It describes a developing field of interventions rather than one standardized treatment with established benefits for every patient.

Three Main Models of Food Is Medicine

International research commonly examines three major approaches: produce prescriptions, medically tailored groceries and medically tailored meals.

Although they share the objective of improving access to appropriate food, they differ in how assistance is delivered, the degree of nutritional individualization and the resources required from both providers and recipients.

Produce Prescriptions

Produce prescription programs provide eligible participants with financial assistance or another mechanism for obtaining fruits and vegetables. Depending on the program, eligible foods may also include legumes or other specified products.

In the United States, these programs may use paper vouchers, electronic benefits, debit cards or agreements with participating retailers. Healthcare professionals may refer patients according to defined medical and social criteria.

The word prescription reflects the connection with a healthcare referral or recommendation. It does not mean that fruits and vegetables become regulated prescription medicines or that the assistance automatically qualifies for health insurance reimbursement.

One potential advantage is flexibility. Participants may select eligible foods that suit their preferences, household circumstances and cultural practices.

However, providing financial assistance does not guarantee that patients can use it effectively.

Participants need access to participating retailers, suitable food products, safe storage and, where necessary, the means to prepare meals. A voucher may offer limited practical benefit if eligible stores are difficult to reach, appropriate foods are unavailable or the value of the assistance does not adequately address the financial barrier.

Medically Tailored Groceries

Medically tailored grocery programs supply ingredients or food packages selected according to defined nutritional or clinical considerations.

These packages may contain combinations of vegetables, fruits, whole grains, legumes and other foods intended to support particular dietary needs.

For example, a grocery package designed for someone with hypertension may emphasize an appropriate dietary pattern while considering sodium intake. Patients with other medical conditions may require different nutritional considerations.

The term medically tailored should be used carefully. A package containing generally nutritious ingredients is not necessarily individualized medical nutrition care.

Meaningful tailoring requires an appropriate understanding of the recipient's condition, nutritional needs and relevant dietary restrictions. Depending on the intervention, this may require assessment or oversight by qualified healthcare professionals.

Groceries also need to be prepared. This model may be practical for households that regularly cook together but less suitable for patients who cannot cook independently, have limited kitchen facilities or experience significant functional limitations.

Medically Tailored Meals

Medically tailored meals are prepared meals designed to meet specified nutritional requirements associated with particular medical conditions.

They may be developed with the involvement of qualified nutrition professionals and supplied to eligible patients through a healthcare-connected program.

This approach may be useful when a person has difficulty shopping or preparing food because of illness, disability or other circumstances.

However, prepared meal programs involve substantial operational requirements. Menus must be developed, ingredients sourced, meals prepared, stored and transported safely, and delivery arrangements maintained reliably.

Clinical suitability also requires attention. A meal appropriate for one patient with diabetes may be unsuitable for someone who also has advanced kidney disease, severe food allergies, swallowing difficulties or another condition requiring specialized nutritional management.

Prepared meals are therefore not inherently more effective or safer than groceries or produce subsidies. Their suitability depends on the intended population, clinical requirements and quality of delivery.

These models should not be treated as interchangeable when interpreting research. Evidence concerning one type of intervention does not automatically establish that another will produce the same outcomes.

What Does the Scientific Evidence Support?

Research on Food Is Medicine has expanded, but the strength of the evidence varies considerably across interventions and outcomes.

In June 2025, the American Heart Association (AHA) published a scientific statement in Circulation reviewing randomized controlled trials of Food Is Medicine interventions for noncommunicable diseases in the United States.[2]

The review identified 14 randomized controlled trials. Many were relatively small or early-stage studies, and the interventions differed in their target populations, duration, intensity and delivery models.

Results were generally encouraging for dietary quality and food security. However, effects on clinical outcomes were inconsistent and frequently did not reach statistical significance.

This distinction is important when interpreting the field.

Improving access to nutritious food is a valuable outcome, especially for people experiencing food insecurity. Better dietary quality may also contribute to health. Nevertheless, these improvements do not automatically demonstrate reductions in HbA1c, cardiovascular events, hospital admissions or mortality.

A program may successfully address a food access problem without producing a measurable change in clinical outcomes during the period studied.

A review by Berkowitz, Seligman and Volpp, published online in Annual Review of Medicine in August 2026, similarly described promising findings alongside meaningful limitations and unexpected results.[3]

The authors highlighted the importance of understanding why interventions perform differently across settings and populations, particularly when programs move from small studies into broader healthcare implementation.

The September 2026 ACC scientific statement also recognized the potential of Food Is Medicine while emphasizing the importance of incorporating evidence-based nutrition education to support sustained dietary improvement.[1]

Taken together, these publications support continued research and carefully designed implementation. They do not establish that every Food Is Medicine program delivers clinically important benefits or represents a cost-effective alternative to existing healthcare services.

What Recent Randomized Trials Have Found

Several randomized trials demonstrate why Food Is Medicine requires careful evaluation rather than an assumption that providing healthier food will automatically improve disease control.

A study published in JAMA Internal Medicine in 2024 examined an intensive Food-as-Medicine program for adults with diabetes experiencing food insecurity.[4]

The intervention combined healthy groceries with dietitian consultations, diabetes education and health coaching.

The researchers randomized 500 participants, of whom 465 completed the study. At the six-month assessment, HbA1c laboratory results were available for 349 participants.

Both the intervention and control groups experienced reductions in HbA1c. However, the adjusted between-group difference was not statistically significant.

The intervention increased engagement with preventive healthcare services, including visits with dietitians, and was associated with favorable changes in some self-reported dietary measures.

This finding is important because the program involved more than food distribution. Despite combining groceries with additional professional support, it did not demonstrate superior glycemic improvement compared with the control condition.

A larger pragmatic randomized clinical trial published in JAMA Internal Medicine in February 2026 evaluated a produce prescription subsidy among 2,155 adults with type 2 diabetes who were at risk of food insecurity.[5]

Participants assigned to the intervention were offered an electronic benefit of US$80 per month for twelve months. The benefit could be used to purchase eligible fresh, frozen or canned fruits, vegetables and legumes.

At twelve months, the program had not improved cardiometabolic outcomes or healthcare utilization compared with usual care.

The adjusted difference in HbA1c was approximately 0.20 percentage points in the direction favoring the usual-care group. The 95% confidence interval ranged from 0.05 to 0.35 percentage points.

The researchers also found no significant between-group differences in emergency department visits, blood pressure, body mass index or inpatient visits.

Benefit utilization was incomplete. Approximately 30% of participants assigned to the intervention used at least 80% of their available monthly benefits.

These results suggest that offering a produce subsidy alone, even when connected to a healthcare system, may not be sufficient to produce the anticipated clinical improvements.

Importantly, the study evaluated the effect of offering the subsidy, not the biological effect of consuming a greater quantity of fruits and vegetables under controlled conditions.

The findings should therefore not be interpreted as evidence that nutritious food is unimportant. They highlight the difference between making a resource available, ensuring that it is used and achieving a measurable health outcome.

Other research has examined whether the amount of financial assistance influences program participation and food consumption.

A randomized community trial published in the Journal of General Internal Medicine in September 2026 compared monthly produce prescription benefits of US$40, US$80 and US$110 over six months among 242 participants.[6]

The findings suggested a dose-response pattern. Higher benefit amounts were associated with more favorable estimates for redemption, food security and fruit and vegetable consumption.

At three months, participants receiving US$110 reported lower food insecurity and greater fruit and vegetable consumption than those receiving US$40, with statistically significant differences in those comparisons.

However, the study primarily evaluated benefit utilization and food-related outcomes, not long-term diabetes control or major clinical events.

Its participant population was also relatively specific. Most participants identified as female and Hispanic, limiting assumptions about how the findings might apply to other populations or healthcare systems.

The results of these trials are not necessarily contradictory. They address different questions.

A larger subsidy may help people obtain and consume more fruits and vegetables. Whether those changes translate into better disease control depends on additional factors, including the overall dietary pattern, medication use, disease severity, duration of the intervention and other aspects of care.

New Evidence Published in Late 2026

Research published toward the end of 2026 provides additional insight into both the potential and limitations of Food Is Medicine.

A pilot randomized controlled trial published in Nature Communications on November 6, 2026, evaluated medically tailored groceries with and without food resource coaching among 210 participants with type 2 diabetes, dyslipidemia or hypertension.[7]

The intervention was delivered through a food pantry located alongside a healthcare service. Participants received usual pantry support, medically tailored groceries, or medically tailored groceries combined with coaching over four months.

Food security, self-reported dietary quality and perceived health improved over time across all three groups.

However, after accounting for baseline differences, the researchers did not identify clear additional benefits from the medically tailored grocery interventions compared with usual food pantry support for the exploratory outcomes examined.

Although reductions in blood pressure appeared larger in the intervention groups, adjusted between-group comparisons were not statistically significant. Confidence intervals were wide, and clinical blood pressure data were available for only part of the study population.

The trial illustrates an important consideration for service development. A more specialized intervention does not necessarily provide greater benefit than an existing form of support.

However, the absence of a demonstrated difference in a small pilot study should not be interpreted as proof that the interventions are equivalent.

A separate observational evaluation published in Current Developments in Nutrition in October 2026 examined 3,056 adults participating in 28 produce prescription programs across the United States.[8]

The proportion of participants reporting low or very low household food security decreased from 67.2% at baseline to 55.2% at follow-up.

Average reported fruit and vegetable intake increased from approximately 2.41 to 2.56 cups per day, while participants also reported modest improvements in their overall health.

These findings are encouraging because they come from multiple programs and a relatively large participant population.

However, the analysis used a before-and-after design without a randomized control group. It cannot establish with certainty that the observed improvements were caused by the produce prescription programs.

Participants' circumstances may have changed over time, and other factors could have contributed to the findings.

The distinction between these two studies matters. Randomized trials can provide stronger evidence for causal effects, while observational program evaluations may help explain participation, feasibility and outcomes under real-world conditions.

Both contribute useful information, but they should not be interpreted as providing the same level of evidence.

Findings concerning medically tailored meals also remain mixed.

A randomized clinical trial published in JAMA Cardiology in April 2026 evaluated food supplementation through medically tailored meals or fresh produce among 150 patients recently hospitalized for heart failure.[9]

The study found that food supplementation was feasible and generally well accepted. Fresh produce demonstrated greater acceptability than medically tailored meals in the study setting.

However, the intervention did not significantly reduce the primary clinical outcome of heart failure-related hospitalization or emergency department visits during the ninety-day follow-up period.

An exploratory hierarchical composite outcome favored food supplementation, but this finding should be distinguished from the absence of improvement in the prespecified primary outcome.

The relatively small sample and short follow-up also limit conclusions about longer-term effects.

Overall, these studies suggest that Food Is Medicine interventions can be delivered successfully and may improve selected food-related outcomes. Establishing consistent clinical effectiveness remains a separate and more demanding challenge.

Food Security and Clinical Effectiveness Are Different Questions

Food insecurity involves difficulty obtaining sufficient and appropriate food because of financial or other barriers affecting access.

For people living with chronic conditions, these difficulties may have consequences beyond dietary quality.

A patient may need to choose between purchasing groceries, paying for medication or covering transportation to medical appointments. Limited food access may also complicate medication management and contribute to stress.

Food assistance may reduce some of these pressures even when a short-term study does not detect a statistically significant improvement in HbA1c or another clinical measure.

This creates an important distinction between the social value and clinical effectiveness of a program.

An intervention may be justified primarily because it reduces food insecurity. A healthcare-connected Food Is Medicine program may aim to achieve that objective while also improving disease management or other clinical outcomes.

Both objectives can be legitimate, but each requires appropriate evidence.

If the purpose is to improve food access, evaluation should examine whether participants can obtain sufficient and suitable food more consistently.

If the purpose is to improve diabetes control, the program should measure relevant clinical outcomes and consider other factors that may influence them.

If the objective is to reduce hospital utilization, the evaluation must directly examine admissions, emergency department visits or other relevant healthcare use.

It would be misleading to claim that a program prevents hospitalization simply because participants receive more vegetables.

Equally, a study showing no significant improvement in glycemic control does not establish that reducing food insecurity has no value.

Healthcare organizations should be clear about the outcomes their programs are designed to achieve and avoid extending claims beyond the evidence.

Identifying Patients Who May Benefit

Not every patient receiving healthcare requires the same form of nutritional support.

A person with reliable access to appropriate food may benefit more from individualized dietary counseling than from a food subsidy.

Another patient may understand their nutritional needs but be unable to obtain suitable groceries consistently because of financial hardship.

Someone with significant functional limitations may have sufficient financial resources yet struggle to shop or prepare meals independently.

These situations call for different responses.

Patient selection should begin with an assessment of the actual problem the program intends to address.

Relevant considerations may include food access, individual nutritional requirements, clinical conditions, the ability to store and prepare food, household circumstances and the availability of other support services.

Food insecurity should not be inferred solely from appearance, diagnosis, occupation or perceived socioeconomic status.

Where screening is used, it should be conducted respectfully, with clear information about its purpose and appropriate safeguards for personal information.

Patients should not be made to feel that they have failed to follow medical advice when structural, financial or environmental barriers are beyond their immediate control.

Eligibility criteria should also be transparent.

A program designed for adults with diabetes who experience difficulty accessing nutritious food should not automatically be promoted as appropriate for everyone with diabetes.

Where resources are limited, selection should be based on defensible clinical and social criteria rather than informal preferences or commercial considerations.

The needs of the intended population should shape the intervention, rather than requiring patients to fit a predetermined program.

Clinical Nutrition Safety Must Accompany Food Provision

Providing food through a healthcare-connected program introduces responsibilities beyond ordinary nutrition education.

A food package may be generally nutritious but inappropriate for a particular patient.

Someone with advanced chronic kidney disease may require individualized management of potassium, phosphorus, protein, sodium or fluid intake according to their clinical condition and treatment.

A patient who substantially changes food intake while using insulin or certain other glucose-lowering medications may require closer glucose monitoring and professional review of treatment.

People with swallowing difficulties, severe food allergies, malnutrition or other complex conditions may need specialized nutritional assessment before receiving standardized meals.

These considerations do not mean that patients with complex conditions should automatically be excluded. They mean that programs need reliable processes for identifying when individual clinical assessment and nutritional modification are necessary.

Clinical nutrition decisions should remain with appropriately qualified healthcare professionals acting within their lawful responsibilities.

Food suppliers, community organizations and delivery partners may contribute valuable services, but they should not independently diagnose medical conditions or change treatment recommendations outside their authorized roles.

A distinction should also be maintained between medically tailored meals and regulated foods for special medical purposes.

An ordinary prepared meal designed to support a patient's dietary needs does not automatically become a regulated medical nutrition product. The phrase medically tailored describes an approach to food provision; it does not independently determine the product's legal classification.

Food safety requires separate attention.

A meal may be nutritionally appropriate but unsafe because of contamination, inadequate storage or improper transportation. Conversely, a safely prepared meal may still be unsuitable for someone with specific medical restrictions.

Supplier assessment, ingredient traceability, allergen management, food preparation, storage, temperature control where applicable, labeling and response to food safety incidents should therefore form part of program planning.

These safeguards become particularly important when programs serve medically vulnerable individuals.

Adapting Food Is Medicine to Vietnamese Circumstances

Most published Food Is Medicine research comes from the United States, where healthcare financing, food assistance arrangements and retail infrastructure differ substantially from those in Viet Nam.

These differences matter when considering local implementation.

Vietnamese food practices are shaped by family meals, regional dietary traditions, traditional markets, local food availability and household resources.

Income, employment, transportation, cooking facilities and access to healthcare also vary considerably between communities.

A produce prescription program based on electronic vouchers redeemable at supermarket chains may work for some urban patients but be less convenient for people who regularly purchase food at traditional markets.

A prepared meal delivery program may be appropriate in selected settings but difficult to sustain when production, storage and transportation costs are substantial.

Medically tailored groceries may offer flexibility for households that prepare shared meals. However, the approach may be less useful for patients who cannot cook independently or lack adequate kitchen facilities.

These differences suggest that Vietnamese programs should begin with local needs and resources rather than attempt to reproduce an imported operational model.

A healthcare organization might first examine why particular patients have difficulty following appropriate dietary recommendations.

Some may need better access to qualified nutrition professionals. Others may benefit from practical meal preparation education, assistance with food purchasing or connections to available community support.

Only some of these situations may justify a structured Food Is Medicine intervention.

Cultural adaptation should also recognize the nutritional potential of familiar Vietnamese foods.

A program does not necessarily require imported ingredients or the direct replication of a foreign dietary pattern. Locally available vegetables, fruits, legumes, whole grains and other appropriate foods can support evidence-based nutritional approaches.

At the same time, familiar foods are not automatically suitable for every clinical condition. Nutritional quality, preparation methods, portion sizes and individual requirements remain important.

The objective is to translate reliable nutritional evidence into realistic food choices that reflect the patient's circumstances.

From Patient Need to a Practical Pilot

An organization considering a Food Is Medicine pilot should begin by identifying a specific problem and defining the population it intends to support.

Consider a hypothetical hospital outpatient service caring for adults with type 2 diabetes.

Clinicians notice that some patients struggle to follow appropriate dietary recommendations because of financial constraints and inconsistent access to nutritious food.

Rather than immediately launching a large food distribution program, the hospital could first examine the nature and extent of the problem.

The assessment might consider whether patients can afford recommended ingredients, whether suitable foods are available near their homes, whether they have the facilities and ability to prepare meals, and whether existing community support services can address their needs.

Different patients may require different solutions.

Some may benefit from individualized nutrition counseling. Others may need practical cooking support or help accessing existing social assistance. A smaller group with persistent food access difficulties may be suitable for evaluating a structured food provision intervention.

For that group, the hospital could consider a limited partnership with an appropriately qualified food supplier or community organization.

The program would need to define eligible foods, nutritional considerations, participant selection criteria, duration, expected outcomes and the responsibilities of participating organizations.

Healthcare professionals would remain responsible for clinical assessment and treatment decisions. Qualified nutrition professionals could contribute to dietary planning and monitoring according to their authorized scope. Food partners would be accountable for the supply activities they undertake, including applicable quality and safety requirements.

Participants should receive clear information about the purpose of the program, what assistance is available, whether participation is voluntary, how personal information may be shared and what happens when support ends.

The program should also establish arrangements for responding to delivery failures, unsuitable food packages, food safety incidents and changes in patients' clinical conditions.

A small feasibility project may be an appropriate first step.

It could examine whether eligible patients can be identified, whether intended foods can be supplied consistently, whether participants use the assistance and whether the approach is acceptable to patients and healthcare teams.

However, feasibility should not be confused with clinical effectiveness.

A program that can deliver food reliably has demonstrated an operational capability. Whether it improves clinical outcomes remains a separate question requiring appropriate evaluation.

This example is illustrative. It does not describe an existing VLMA service, a validated Vietnamese Food Is Medicine protocol or an independently authorized clinical implementation model.

Any actual project would require appropriate professional, institutional and legal review.

Measuring Outcomes That Matter

A Food Is Medicine program should not be judged solely by the number of vouchers issued, meals delivered or patients enrolled.

These figures describe program activity, but they do not establish whether participants received appropriate food, changed their dietary patterns or experienced meaningful improvements in health.

Evaluation should begin with the intended purpose of the intervention.

For produce prescriptions, relevant measures may include benefit redemption, access to eligible foods, fruit and vegetable intake and food security.

For medically tailored groceries, evaluation may also examine whether ingredients are appropriate, usable and incorporated into meals.

For prepared meals, relevant measures include nutritional suitability, delivery reliability, food safety, patient acceptance and whether the meals are consumed as intended.

When clinical benefit is a stated objective, the evaluation should include appropriate clinical and patient-relevant outcomes.

These may include disease-specific indicators, treatment-related complications, functional outcomes or healthcare utilization, depending on the intervention.

The relationship between food assistance and clinical improvement should be interpreted cautiously.

A patient may receive food assistance while also undergoing medication adjustments, additional follow-up or other interventions. Observed improvements cannot automatically be attributed to the food program alone.

Where feasible, evaluation should use a credible comparison group or another study design appropriate to the research question.

Incomplete participation and missing follow-up information also matter.

Programs should avoid evaluating only individuals who consistently redeem benefits or complete all planned activities and then generalizing those findings to everyone who was offered assistance.

Patients who participate inconsistently may be those facing the greatest barriers.

Sustainability should also be considered. A short-term subsidy may improve access while support is available, but the original difficulties may return once assistance ends.

Claims of healthcare savings require particular care.

Food procurement, professional time, administration, storage, transportation, monitoring and evaluation all involve costs.

A program may provide meaningful social or clinical benefits without reducing healthcare expenditure. Conversely, cost savings should not be assumed simply because the intervention addresses a recognized health risk.

A credible economic evaluation should define the relevant costs, intended outcomes, comparison and time horizon.

Partnerships, Sponsorship and Professional Independence

Food Is Medicine programs often depend on cooperation between organizations with different responsibilities and objectives.

Healthcare facilities may work with food suppliers, retailers, community organizations, researchers, charitable foundations or private companies.

Such partnerships can improve access to resources, but they can also introduce conflicts of interest.

A food supplier may have legitimate commercial objectives. A healthcare organization must maintain professional judgment and prioritize patient welfare and the integrity of clinical information.

Patient eligibility, nutritional suitability and clinical recommendations should be determined through appropriate professional processes rather than commercial incentives.

Sponsorship should not influence scientific conclusions, research outcomes, patient selection or the content of professional education.

Supporting a program should not automatically entitle a company to promote its products as clinically superior or as proven treatments without sufficient evidence.

Organizations should also distinguish between charitable donations, commercial supply arrangements, research collaborations and clinical service contracts.

Each may involve different responsibilities concerning procurement, financial transparency, personal-data processing and public communication.

The term Food Is Medicine should not become a marketing claim implying that an ordinary food product has independently demonstrated disease-treatment effects.

The involvement of physicians or professional organizations does not automatically establish that a particular food, product or supplier is clinically superior.

Responsible collaboration requires transparency about financial relationships and a clear separation between evidence-based professional education and commercial promotion.

The Legal and Regulatory Context in Viet Nam

Food Is Medicine is an internationally used concept. It is not, by itself, a separate professional licensing category, clinical service authorization or nationally established healthcare reimbursement model in Viet Nam.

Any implementation must therefore be assessed according to the activities actually undertaken.

Medical examination and treatment are governed by the Law on Medical Examination and Treatment No. 15/2023/QH15, as amended and reflected in Consolidated Document No. 26/VBHN-VPQH dated February 26, 2026.[10]

This framework is relevant where a Food Is Medicine intervention involves individualized clinical nutritional assessment, medical treatment decisions or other regulated healthcare activities.

Hospital nutrition activities are also addressed by Circular No. 18/2020/TT-BYT, as amended and reflected in Consolidated Document No. 16/VBHN-BYT dated December 9, 2025.[11]

Decision No. 2598/QĐ-BYT, dated August 18, 2025, issued professional technical guidance covering 36 clinical nutrition procedures, applicable to healthcare facilities from July 1, 2026.[12]

These documents provide a professional framework for relevant clinical nutrition activities. However, they do not automatically authorize organizations to provide regulated medical nutrition services outside their legally permitted activities or professional scopes.

The preventive healthcare framework has also developed.

The Law on Disease Prevention No. 114/2025/QH15 took effect on July 1, 2026, and includes provisions concerning nutrition in disease prevention.[13]

Decision No. 1982/QĐ-BYT, dated July 1, 2026, issued professional guidance on measures for implementing nutrition in disease prevention.[14]

These instruments are relevant to prevention-oriented nutrition activities. Their existence does not independently authorize every form of food subsidy, prepared meal delivery or commercial healthcare-connected program.

Food production, preparation, supply, distribution and marketing remain subject to the applicable food safety and commercial framework.

The Law on Food Safety No. 55/2010/QH12, as amended, provides the foundational legal requirements together with its applicable implementing regulations.[15]

An important regulatory development occurred in April 2026.

Government Resolution No. 15/2026/NQ-CP, dated April 6, 2026, temporarily suspended the application of Decree No. 46/2026/NĐ-CP and Resolution No. 66.13/2026/NQ-CP until the amended Food Safety Law and its implementing decree take effect, as provided in the Resolution.[16]

During the specified suspension period, Decree No. 15/2018/NĐ-CP and its relevant implementing provisions continue to apply.

As of November 21, 2026, the amended Food Safety Law had not yet been enacted. The revised legislation was still progressing through the legislative process.

This distinction is important because Food Is Medicine initiatives may involve activities subject to different regulatory requirements, including food preparation, processing, storage, transportation, distribution and the supply of products within particular legal categories.

Organizations should establish the correct regulatory classification according to their actual products and activities rather than assume that describing a program as a healthcare intervention changes the applicable requirements.

Public communication must also comply with applicable advertising rules, including the Law on Advertising as amended by Law No. 75/2025/QH15, effective January 1, 2026.[17]

A produce prescription should not be represented as a regulated pharmaceutical prescription or as an independently reimbursable medical service.

Likewise, the existence of international Food Is Medicine programs does not establish automatic coverage through Vietnamese health insurance.

Clinical service charges, financial assistance and reimbursement arrangements must be assessed separately under the relevant Vietnamese requirements and contractual conditions.

Patient Information, Data Protection and Research Ethics

Food Is Medicine programs may require coordination between healthcare organizations and partners providing food or financial support.

This can involve sensitive patient information.

A healthcare team may need to identify a patient's medical condition or nutritional requirements. A food supplier may require information about dietary restrictions, allergens, delivery arrangements or other details necessary to provide the agreed service.

However, the supplier does not necessarily need the patient's complete diagnosis, medical history or clinical record.

Information sharing should be limited to what is necessary and legally appropriate for each party's responsibilities.

The Law on Personal Data Protection No. 91/2025/QH15 and Decree No. 356/2025/NĐ-CP, both effective January 1, 2026, establish important obligations concerning personal-data processing and protection.[18,19]

Decree No. 102/2025/NĐ-CP, effective July 1, 2025, also governs health data management within its defined scope.[20]

Healthcare organizations and partners should establish appropriate arrangements covering the purposes and lawful bases of processing, patient information, access restrictions, security measures, retention and any disclosure to other parties.

Participation in food assistance should not automatically be treated as permission to use identifiable patient information for unrelated research, advertising or commercial purposes.

Digital vouchers, electronic benefit systems and linked clinical databases may support monitoring and evaluation, but they also introduce risks concerning access control, data security and unnecessary collection of personal information.

The convenience of collecting data does not remove the need to justify why they are required.

Where a pilot constitutes biomedical research involving human participants or otherwise requires ethics review, the responsible organization must consider the applicable institutional and regulatory requirements.

Circular No. 43/2024/TT-BYT, effective February 1, 2025, regulates the establishment, organization and operation of ethics committees in biomedical research.[21]

Describing an activity as a pilot, service evaluation or quality improvement project does not automatically determine whether ethics review is required. That determination depends on the actual design and activities involved, together with the applicable requirements.

What Vietnamese Healthcare Can Learn From International Experience

International Food Is Medicine research offers useful lessons, even though it does not provide a ready-made model for Viet Nam.

One lesson is that food access and clinical nutrition care are complementary but distinct concerns. Appropriate medical advice does not necessarily remove financial or environmental barriers, while food assistance does not replace individualized clinical assessment.

Another is that the intervention itself matters.

A produce subsidy, a medically tailored grocery package and a prepared meal service differ in their cost, intensity, practical requirements and suitability for particular patients.

They should not be expected to produce identical outcomes.

Recent randomized trials also demonstrate that better food access does not necessarily lead to measurable improvements in disease indicators or healthcare utilization.

This does not diminish the importance of nutrition. It shows that providing a resource and producing a clinical outcome are different steps in a complex process.

Implementation is equally important.

A well-designed subsidy may achieve limited benefit if participants cannot reach participating retailers or do not use the assistance consistently.

A grocery package may be nutritionally appropriate but impractical for someone who cannot prepare meals independently. A prepared meal service may be clinically suitable but difficult to sustain because of production and delivery costs.

Social value should also be evaluated on its own terms.

An intervention that meaningfully reduces food insecurity may provide important support even when it has not demonstrated reductions in hospital admissions or healthcare expenditure.

Programs also need to be evaluated in the settings where they are delivered.

The financial, social, cultural and operational conditions influencing food access in Viet Nam may differ substantially from those represented in international studies.

A responsible response is neither to dismiss Food Is Medicine because some trials have reported null findings nor to promote it as an established solution for chronic disease.

It is to identify appropriate applications, acknowledge uncertainty and evaluate outcomes before making broader claims.

From an Appealing Concept to Responsible Practice

Food Is Medicine reflects an important recognition: healthcare recommendations cannot always be separated from the practical circumstances in which people obtain, prepare and consume food.

For a patient who cannot reliably access appropriate ingredients, additional nutrition advice may not be enough. Practical assistance may help address a barrier that conventional clinical care alone cannot resolve.

However, connecting food provision with healthcare introduces responsibilities that require careful attention.

Food must be suitable for the intended recipients, prepared and distributed safely, and supported by appropriate clinical oversight when individualized nutritional management is necessary.

Programs must also protect patient choice, personal information, professional independence and financial transparency.

The scientific evidence supports a measured approach.

The 2025 AHA systematic review, the 2026 ACC scientific statement and recent randomized trials demonstrate growing professional interest in Food Is Medicine and its potential to improve access to nutritious food.

They also show that benefits vary across interventions and populations. Improvements in food security, dietary quality or participation should not automatically be presented as evidence of better disease control.

For Vietnamese healthcare organizations, the most useful starting point is a clearly identified patient need rather than an imported program or an appealing name.

A responsible intervention should be able to explain whom it is intended to help, why the proposed support is appropriate, what evidence supports its use and how its effects will be evaluated.

The subject is relevant to evidence-based Lifestyle Medicine because it connects nutritional recommendations with the circumstances that influence whether patients can follow them.

For the Vietnam Lifestyle Medicine Alliance (VLMA), Food Is Medicine provides an opportunity for professional education, critical appraisal of emerging research and discussion of responsible implementation within Vietnamese healthcare.

The purpose is not to present food as a replacement for medical treatment or to endorse particular commercial nutrition products.

It is to encourage a more informed understanding of how appropriate food access can complement clinical care, where the evidence remains uncertain and what safeguards are necessary when healthcare organizations participate in food provision.

Ultimately, the value of Food Is Medicine will not be determined by the popularity of the term.

It will depend on whether carefully designed interventions can help people obtain and consume suitable food, achieve meaningful outcomes and operate safely, fairly and sustainably within the healthcare systems and communities they serve.

References and Further Reading
  1. Hu FB, Beleslin B, Blaha MJ, Kris-Etherton PM, Seligman HK, Williams KA Sr. Food and Health: Nutrition for Prevention and Management of Cardiovascular Disease: 2026 ACC Scientific Statement: A Report of the American College of Cardiology. Journal of the American College of Cardiology. Published online September 30, 2026. doi:10.1016/j.jacc.2026.08.025.

  2. Seligman HK, Angell SY, Berkowitz SA, et al. A Systematic Review of "Food Is Medicine" Randomized Controlled Trials for Noncommunicable Disease in the United States: A Scientific Statement From the American Heart Association. Circulation. 2025;152(4):e32–e46. doi:10.1161/CIR.0000000000001343.

  3. Berkowitz SA, Seligman HK, Volpp KG. Food Is Medicine Interventions to Improve Health. Annual Review of Medicine. Published online August 14, 2026, ahead of the 2027 volume. doi:10.1146/annurev-med-042325-042333.

  4. Doyle J, Alsan M, Skelley N, Lu Y, Cawley J. Effect of an Intensive Food-as-Medicine Program on Health and Health Care Use: A Randomized Clinical Trial. JAMA Internal Medicine. 2024;184(2):154–163. doi:10.1001/jamainternmed.2023.6670.

  5. Drake C, Buckman C, Brucker A, et al. Produce Prescription Subsidy for Patients With Diabetes: A Pragmatic Randomized Clinical Trial. JAMA Internal Medicine. 2026;186(4):416–424. doi:10.1001/jamainternmed.2025.8008.

  6. Kane RM, Perez-Velazco X, Levi R, et al. Produce Prescription Dose Response: A Randomized Community Trial. Journal of General Internal Medicine. Published online September 15, 2026. doi:10.1007/s11606-026-10773-0.

  7. Hollis-Hansen K, Vonderschmidt A, Albin JL, et al. A Pilot Randomized Controlled Trial of Medically Tailored Groceries and Resource Coaching: Secondary and Exploratory Diet and Health Outcomes. Nature Communications. Published online November 6, 2026. doi:10.1038/s41467-026-79207-z.

  8. Yaroch AL, Zigmont VA, Long CR, et al. Food Is Medicine in Action: Outcomes for 28 National Produce Prescriptions Through the Gus Shumacher Nutrition Incentive Program. Current Developments in Nutrition. 2026;10(11):109568. doi:10.1016/j.cdnut.2026.109568.

  9. Pandey A, Keshvani N, Coellar JD, et al. Food Supplementation in Patients Hospitalized for Heart Failure: A Randomized Clinical Trial. JAMA Cardiology. 2026;11(6):564–573. doi:10.1001/jamacardio.2026.0435.

  10. National Assembly of Viet Nam. Law on Medical Examination and Treatment No. 15/2023/QH15, January 9, 2023, as amended. Office of the National Assembly, Consolidated Document No. 26/VBHN-VPQH, February 26, 2026.

  11. Ministry of Health of Viet Nam. Circular No. 18/2020/TT-BYT on Nutrition Activities in Hospitals, November 12, 2020, as amended. Consolidated Document No. 16/VBHN-BYT, December 9, 2025.

  12. Ministry of Health of Viet Nam. Decision No. 2598/QĐ-BYT, August 18, 2025, Issuing Professional Technical Guidance on Clinical Nutrition Procedures. Applicable from July 1, 2026.

  13. National Assembly of Viet Nam. Law on Disease Prevention No. 114/2025/QH15, December 10, 2025. Effective July 1, 2026.

  14. Ministry of Health of Viet Nam. Decision No. 1982/QĐ-BYT, July 1, 2026, Issuing Professional Guidance on Measures for Implementing Nutrition in Disease Prevention.

  15. National Assembly of Viet Nam. Law on Food Safety No. 55/2010/QH12, June 28, 2010, as amended, together with applicable implementing regulations.

  16. Government of Viet Nam. Resolution No. 15/2026/NQ-CP, April 6, 2026, Temporarily Suspending the Application of Decree No. 46/2026/NĐ-CP and Resolution No. 66.13/2026/NQ-CP During the Specified Period. Decree No. 15/2018/NĐ-CP Continues to Apply During the Suspension Period.

  17. National Assembly of Viet Nam. Law No. 75/2025/QH15, June 16, 2025, Amending and Supplementing the Law on Advertising. Effective January 1, 2026.

  18. National Assembly of Viet Nam. Law on Personal Data Protection No. 91/2025/QH15, June 26, 2025. Effective January 1, 2026.

  19. Government of Viet Nam. Decree No. 356/2025/NĐ-CP, December 31, 2025, Detailing Selected Provisions and Implementation Measures of the Law on Personal Data Protection. Effective January 1, 2026.

  20. Government of Viet Nam. Decree No. 102/2025/NĐ-CP, May 13, 2025, on Health Data Management. Effective July 1, 2025.

  21. Ministry of Health of Viet Nam. Circular No. 43/2024/TT-BYT, December 12, 2024, Regulating the Establishment, Organization and Operation of Ethics Committees in Biomedical Research. Effective February 1, 2025.

Editorial, Clinical and Regulatory Note

This article is published by the Vietnam Lifestyle Medicine Alliance (VLMA) for professional education, scientific knowledge exchange, critical appraisal of research and discussion of responsible implementation of evidence-based Lifestyle Medicine in Viet Nam.

It provides an educational review of selected international Food Is Medicine models, research findings and relevant Vietnamese regulatory considerations. It does not constitute a Vietnamese national clinical guideline, an approved medical nutrition protocol, a food safety certification, a regulated prescription framework, a healthcare reimbursement determination or an authoritative legal opinion.

The terms Food Is Medicine, produce prescription, medically tailored groceries and medically tailored meals describe approaches discussed in international scientific literature. Their use does not independently establish a legal category, professional qualification or authorization to provide regulated clinical services in Viet Nam.

Examples of proposed services, partnerships and pilot programs are illustrative. They are not presented as interventions already implemented, formally validated, clinically endorsed or independently authorized by VLMA.

Food assistance must not replace necessary medical examination, diagnosis, treatment, clinical nutrition management, medication monitoring or specialist referral. Where individualized clinical nutrition interventions are required, they must be provided or supervised by appropriately qualified and authorized healthcare professionals.

Organizations involved in food preparation, supply, distribution or marketing must comply with the applicable Vietnamese food safety, labeling, advertising, commercial and other legal requirements relevant to their activities.

International Food Is Medicine research does not establish that particular foods, prepared meals, food packages or commercial products independently prevent, treat or cure disease. Improvements in dietary quality or food security should not be presented as proof of improved clinical outcomes, reduced hospital admissions or lower healthcare costs without adequate supporting evidence.

The collection, use and disclosure of identifiable patient information must comply with applicable personal-data protection, healthcare confidentiality and health-data governance requirements.

Research involving human participants or other activities requiring ethical review must follow the relevant institutional and Vietnamese regulatory processes.

VLMA does not independently license healthcare professionals, authorize regulated clinical food provision services, certify Food Is Medicine programs for regulatory purposes, approve biomedical research or endorse particular commercial food products or suppliers through this article.

The scientific and regulatory materials referenced were reviewed through November 21, 2026. Organizations considering practical implementation should verify the current legal requirements, applicable clinical guidance and regulatory classification of their proposed activities before commencing any program or making patient-facing claims.

Vietnam Lifestyle Medicine Alliance

Evidence-Based Lifestyle Medicine for Viet Nam.

Contact

contact@vlma.org

Saigon Paragon Building, No. 3 Nguyen Luong Bang Street, Tan My Ward, HCMC

+84 909 228 476

+84 84 9999 911

© 2025 - 2026. Vietnam Lifestyle Medicine Alliance. All rights reserved.

A physician-led professional platform advancing Lifestyle Medicine through education, collaboration, research, and responsible implementation.

VLMA is operated by Vietnam Lifestyle Medicine Alliance Company Limited, Enterprise Registration Number 0318902666.

VLMA is a Sister Organization of the Lifestyle Medicine Global Alliance and a Member Organization of the Planetary Health Alliance.

VLMA is not a medical service provider and does not issue medical licenses or IBLM certification.